Contact number
213 485 1234Provided by Chambers
Latham & Watkins LLP offers a high-end corporate practice recognized for its expert capital markets team as well as its handling of complex M&A, collaboration and licensing deals. The firm also provides skillful counsel on regulatory compliance to pharmaceutical and medical device companies on a range of matters including new product approvals and marketing materials.
Latham & Watkins advised oncology company Merus in its $8 billion sale to biotechnology company Genmab.
Provided by Chambers
Latham is an extremely experienced team, that are good at keeping up with the tide and bringing understanding to the regulatory matters we face.
Latham is an extremely experienced team, that are good at keeping up with the tide and bringing understanding to the regulatory matters we face.
Provided by Chambers
Michael Morin is global chair of intellectual property litigation practice at Latham & Watkins. He is known for his extensive representations of large pharmaceutical companies in connection with patent and copyright infringement matters.
Mike is an excellent lawyer and leads an excellent team.
Cheston Larson advises biotech and other life sciences companies through all stages of their life cycle. His practice focuses on corporate and financing transactions. His work covers venture financing, IPOs and M&A transactions.
John Manthei is global chair of the healthcare and life sciences practice. He advises pharmaceuticals, biotechnology and medical device companies on all manner of FDA and other regulatory procedures governing the life sciences sector. His expertise includes the negotiation of clinical trial agreements, pre-market product development and the regulation of marketing materials.